These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 15853834)

  • 1. Glycodelin responses to hyperinsulinaemic clamp vary according to basal serum glycodelin concentration.
    Seppälä M; Mandelin E; Koistinen R; Bergholm R; Tiikkainen M; Yki-Järvinen H
    Clin Endocrinol (Oxf); 2005 May; 62(5):611-5. PubMed ID: 15853834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal evaluation and midcycle detection of intrauterine glycodelin in women treated with levonorgestrel as in emergency contraception.
    Durand M; Koistinen R; Chirinos M; Rodríguez JL; Zambrano E; Seppälä M; Larrea F
    Contraception; 2010 Dec; 82(6):526-33. PubMed ID: 21074015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome.
    Jakubowicz DJ; Seppälä M; Jakubowicz S; Rodriguez-Armas O; Rivas-Santiago A; Koistinen H; Koistinen R; Nestler JE
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1126-33. PubMed ID: 11238496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late follicular phase administration of levonorgestrel as an emergency contraceptive changes the secretory pattern of glycodelin in serum and endometrium during the luteal phase of the menstrual cycle.
    Durand M; Seppala M; Cravioto Mdel C; Koistinen H; Koistinen R; González-Macedo J; Larrea F
    Contraception; 2005 Jun; 71(6):451-7. PubMed ID: 15914136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single midcycle dose of levonorgestrel similar to emergency contraceptive does not alter the expression of the L-selectin ligand or molecular markers of endometrial receptivity.
    Palomino WA; Kohen P; Devoto L
    Fertil Steril; 2010 Oct; 94(5):1589-94. PubMed ID: 19909947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum glycodelin pattern during the menstrual cycle in healthy young women.
    Bersinger NA; Birkhäuser MH; Yared M; Wunder DM
    Acta Obstet Gynecol Scand; 2009; 88(11):1215-21. PubMed ID: 19900139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy.
    Jakubowicz DJ; Essah PA; Seppälä M; Jakubowicz S; Baillargeon JP; Koistinen R; Nestler JE
    J Clin Endocrinol Metab; 2004 Feb; 89(2):833-9. PubMed ID: 14764802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial expression of glycodelin in women with levonorgestrel-releasing subdermal implants.
    Mandelin E; Koistinen H; Koistinen R; Arola J; Affandi B; Seppälä M
    Fertil Steril; 2001 Sep; 76(3):474-8. PubMed ID: 11532467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P; Lähteenmäki P; Rutanen EM
    Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of relaxin in glycodelin secretion.
    Stewart DR; Erikson MS; Erikson ME; Nakajima ST; Overstreet JW; Lasley BL; Amento EP; Seppala M
    J Clin Endocrinol Metab; 1997 Mar; 82(3):839-46. PubMed ID: 9062493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo assessment of the human sperm acrosome reaction and the expression of glycodelin-A in human endometrium after levonorgestrel-emergency contraceptive pill administration.
    do Nascimento JA; Seppala M; Perdigão A; Espejo-Arce X; Munuce MJ; Hautala L; Koistinen R; Andrade L; Bahamondes L
    Hum Reprod; 2007 Aug; 22(8):2190-5. PubMed ID: 17537781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of two endometrial proteins are not useful for monitoring postmenopausal estrogen/progesterone therapy.
    Ren SG; Braunstein GD; Cedars M; Gambone J; Judd H
    Fertil Steril; 1990 Sep; 54(3):532-4. PubMed ID: 1697814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP-1 and glycodelin serum levels before and after hysterectomy with and without bilateral oophorectomy in premenopausal women.
    Foth D; Meisel M; Nawroth F; Straube W; Römer T
    Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 100(1):55-61. PubMed ID: 11728658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum glycodelin in premature rupture of membranes.
    Loukovaara M; Koistinen R; Kurki T; Seppälä M
    J Perinat Med; 2002; 30(6):480-2. PubMed ID: 12530104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cord serum glycodelin concentrations in normal pregnancies and pregnancies complicated by diabetes.
    Loukovaara M; Leinonen P; Teramo K; Koistinen R
    Arch Gynecol Obstet; 2004 Nov; 270(3):161-4. PubMed ID: 12955531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of a single combined measurement of VEGF, glycodelin, progesterone, PAPP-A, HPL and LIF for differentiating between ectopic and abnormal intrauterine pregnancy.
    Daponte A; Pournaras S; Zintzaras E; Kallitsaris A; Lialios G; Maniatis AN; Messinis IE
    Hum Reprod; 2005 Nov; 20(11):3163-6. PubMed ID: 16055453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in uterine protein research: reproduction and cancer.
    Seppälä M
    Int J Gynaecol Obstet; 2004 May; 85(2):105-18. PubMed ID: 15099771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors.
    Jeschke U; Bischof A; Speer R; Briese V; Richter DU; Bergemann C; Mylonas I; Shabani N; Friese K; Karsten U
    Anticancer Res; 2005; 25(3A):1581-9. PubMed ID: 16033064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.